Concepedia

Kamal K. Balavenkatraman

KK

11

Publications

482

Citations

11

H-Index

2006

Active since

Affiliations

Novartis (Switzerland)(Current)

Friedrich Schiller University Jena

Novartis Institutes for BioMedical Research

University Hospital of Basel

Utrecht University

Kamal K. Balavenkatraman is an author at Novartis (Switzerland) specializing in medicine, cell signaling, and tumor biology.

Top concepts

Publications per year

2006–2023

11

Publications

11

DEP-1 protein tyrosine phosphatase inhibits proliferation and migration of colon carcinoma cells and is upregulated by protective nutrients

Kamal K. Balavenkatraman, Enrico Jandt, Karlheinz Friedrich et al. · Oncogene · 2006 · 74 citations

, , +10

Apple Polyphenols Affect Protein Kinase C Activity and the Onset of Apoptosis in Human Colon Carcinoma Cells

Melanie Kern, Gudrun Pahlke, Kamal K. Balavenkatraman et al. · Journal of Agricultural and Food Chemistry · 2007 · 66 citations

Pharmacological BACE1 and BACE2 inhibition induces hair depigmentation by inhibiting PMEL17 processing in mice

Derya R. Shimshek, Laura H. Jacobson, Carine Kolly et al. · Scientific Reports · 2016 · 66 citations · Full text

The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants

Sylvia Rothenberger, Daniel L. Hurdiss, Marcel Walser et al. · Nature Biotechnology · 2022 · 56 citations · Full text

Loss of the Protein‐Tyrosine Phosphatase DEP‐1/PTPRJ Drives Meningioma Cell Motility

Astrid Petermann, Daniela Haase, Andrea Wetzel et al. · Brain Pathology · 2010 · 48 citations · Full text

, , +18

Rows per page

1–5 of 11